Both infection and endocytic uptake were reduced when some of Cdc42's downstream effectors were inhibited including PAK1 (IPA-3), N-Wasp (wiskostatin), and moderately when Arp2/3 (CK-869) was targeted (Fig. 5E, F). The gene discussed is PAK1; the disease is infection.